No writing assistance was utilized in the production of this manuscript. Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Early ...

Heterozygous familial hypercholesterolemia was associated with increased type 2 diabetes risk, especially among those with obesity and statin use.

WASHINGTON, Oct. 31, 2024 /PRNewswire/ -- As part of its ongoing commitment to raise awareness about heart health and address ...

Escalated doses of lomitapide (5–10 mg/day; orally) with or without ezetimibe have been tested in patients with moderate hypercholesterolemia for a period of 12 weeks. The results indicated a ...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

Spain: A recent phase 3 study, published in The Lancet Diabetes & Endocrinology, has demonstrated the effectiveness of ...

highlights Familial Hypercholesterolemia (FH) during National Sudden Cardiac Arrest Awareness Month. FH is an inherited genetic disorder that results in severely elevated LDL-cholesterol levels.

Familial hypercholesterolemia is an inherited form of very high cholesterol that affects about 1 in 250 people. A gene mutation makes it harder for your liver to remove LDL cholesterol (the “bad ...

Emily F. Gregory, an assistant professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania. ...

Xu M, Wang Z, Zhang Y, et al., on behalf of the REMAIN-1 Investigators. Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial. J Am ...

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology ...

The study aimed to explore the relationship between Achilles tendon thickness (ATT) and LDL cholesterol levels, as well as ...